METTL3 and diffuse large B-cell lymphoma: Furthermore, we used Kaplan‒Meier analysis to compare the overall survival of 50 DLBCL patients with high or low/medium expression of METTL3 (cut off = 50%) collected in Qilu Hospital (Fig. 4D).